US Stock MarketDetailed Quotes

APDN Applied DNA Sciences

Watchlist
  • 0.180
  • -0.006-3.38%
Trading Nov 6 10:07 ET
9.09MMarket Cap-24P/E (TTM)

Applied DNA Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-155.24%-3.49M
-1,597.28%-3.21M
-57.68%-3.76M
30.74%-6.22M
17.76%-2.68M
21.95%-1.37M
181.86%214.39K
35.62%-2.38M
32.95%-8.98M
30.85%-3.26M
Net income from continuing operations
159.39%1.85M
-915.31%-4.49M
70.60%-1.13M
-21.20%-10.02M
-444.07%-3.62M
-176.87%-3.11M
131.32%551.18K
18.57%-3.84M
42.08%-8.27M
85.26%-664.55K
Operating gains losses
-2,180.89%-5.79M
127.56%895.97K
-200.28%-2.64M
88.38%-860.48K
89.32%-519.7K
115.83%278.4K
---3.25M
--2.63M
-747.83%-7.41M
-2,431.25%-4.87M
Depreciation and amortization
-61.57%134.16K
-45.91%186.33K
-11.79%298.95K
5.56%1.36M
0.61%329.68K
8.71%349.15K
7.37%344.5K
5.66%338.92K
52.82%1.29M
9.27%327.68K
Other non cash items
----
----
----
----
----
----
----
----
--1.67M
----
Change In working capital
-151.18%-348.66K
-98.68%30.5K
52.17%-628.05K
156.31%2.45M
401.01%767.6K
27.43%681.25K
37.02%2.31M
-29.81%-1.31M
126.40%954.57K
84.00%-255K
-Change in receivables
-108.40%-105.02K
-97.99%41.9K
71.94%-195.25K
672.48%3.05M
187.68%410.39K
561.30%1.25M
64.30%2.09M
34.55%-695.91K
79.80%-532.96K
77.60%-468.03K
-Change in inventory
-249.37%-133.93K
-62.73%41.35K
-137.74%-47.26K
-64.54%272.22K
-12.60%-53.61K
0.37%89.66K
-83.11%110.93K
80.70%125.23K
187.98%767.69K
94.94%-47.61K
-Change in prepaid assets
-76.95%53.86K
-125.39%-67.33K
-110.28%-13.71K
255.67%767.81K
23.08%135.66K
-2.10%233.63K
132.42%265.15K
649.59%133.37K
-1,721.63%-493.22K
151.88%110.22K
-Change in payables and accrued expense
81.53%-163.57K
132.03%51.32K
34.60%-383.42K
-245.23%-1.35M
-18.46%280.6K
-875.52%-885.47K
-124.95%-160.26K
-244.86%-586.24K
882.46%930.5K
-78.76%344.12K
-Change in other working capital
--0
-490.20%-36.75K
104.00%11.6K
-203.74%-293.12K
97.19%-5.45K
-102.04%-7.41K
114.74%9.42K
-264.09%-289.68K
222.83%282.56K
-787.07%-193.71K
Cash from discontinued investing activities
Operating cash flow
-155.24%-3.49M
-1,597.28%-3.21M
-57.68%-3.76M
30.74%-6.22M
17.76%-2.68M
21.95%-1.37M
181.86%214.39K
35.62%-2.38M
32.95%-8.98M
30.85%-3.26M
Investing cash flow
Cash flow from continuing investing activities
86.51%-21.83K
72.71%-14.83K
0
-123.84%-1.1M
-281.05%-924.67K
-111.02%-161.8K
17.08%-54.34K
142.99%45K
80.79%-489.55K
73.23%-242.66K
Net PPE purchase and sale
9.80%-21.83K
72.71%-14.83K
--0
93.17%-33.45K
100.04%87
68.44%-24.2K
17.08%-54.34K
142.99%45K
80.79%-489.55K
73.23%-242.66K
Net business purchase and sale
----
----
----
---1.06M
----
----
----
----
--0
----
Cash from discontinued investing activities
Investing cash flow
86.51%-21.83K
72.71%-14.83K
--0
-123.84%-1.1M
-281.05%-924.67K
-111.02%-161.8K
17.08%-54.34K
142.99%45K
80.79%-489.55K
73.23%-242.66K
Financing cash flow
Cash flow from continuing financing activities
10.81M
3.02M
-35.08K
0
0
0
0
0
23.27%18.13M
14.03M
Net common stock issuance
--10.81M
--2.93M
--45.57K
--0
--0
--0
--0
--0
4.87%14.43M
--10.33M
Proceeds from stock option exercised by employees
----
----
----
--0
--0
----
----
----
41.55%3.7M
--3.7M
Net other financing activities
----
----
---80.64K
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--10.81M
--3.02M
---35.08K
--0
--0
--0
--0
--0
23.27%18.13M
--14.03M
Net cash flow
Beginning cash position
-70.09%3.9M
-68.09%4.11M
-48.07%7.9M
132.12%15.22M
145.76%11.51M
100.18%13.04M
368.54%12.88M
132.12%15.22M
-15.82%6.55M
-61.54%4.68M
Current changes in cash
576.32%7.29M
-230.84%-209.41K
-62.21%-3.79M
-184.45%-7.31M
-134.22%-3.6M
16.38%-1.53M
-95.75%160.05K
38.58%-2.34M
803.07%8.66M
287.48%10.53M
End cash Position
-2.73%11.19M
-70.09%3.9M
-68.09%4.11M
-48.07%7.9M
-48.07%7.9M
145.76%11.51M
100.18%13.04M
368.54%12.88M
132.12%15.22M
132.12%15.22M
Free cash flow
-129.69%-3.52M
-2,114.90%-3.22M
-57.68%-3.76M
33.49%-6.3M
27.40%-2.54M
16.38%-1.53M
148.88%160.05K
37.40%-2.38M
40.60%-9.47M
37.68%-3.5M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -155.24%-3.49M-1,597.28%-3.21M-57.68%-3.76M30.74%-6.22M17.76%-2.68M21.95%-1.37M181.86%214.39K35.62%-2.38M32.95%-8.98M30.85%-3.26M
Net income from continuing operations 159.39%1.85M-915.31%-4.49M70.60%-1.13M-21.20%-10.02M-444.07%-3.62M-176.87%-3.11M131.32%551.18K18.57%-3.84M42.08%-8.27M85.26%-664.55K
Operating gains losses -2,180.89%-5.79M127.56%895.97K-200.28%-2.64M88.38%-860.48K89.32%-519.7K115.83%278.4K---3.25M--2.63M-747.83%-7.41M-2,431.25%-4.87M
Depreciation and amortization -61.57%134.16K-45.91%186.33K-11.79%298.95K5.56%1.36M0.61%329.68K8.71%349.15K7.37%344.5K5.66%338.92K52.82%1.29M9.27%327.68K
Other non cash items ----------------------------------1.67M----
Change In working capital -151.18%-348.66K-98.68%30.5K52.17%-628.05K156.31%2.45M401.01%767.6K27.43%681.25K37.02%2.31M-29.81%-1.31M126.40%954.57K84.00%-255K
-Change in receivables -108.40%-105.02K-97.99%41.9K71.94%-195.25K672.48%3.05M187.68%410.39K561.30%1.25M64.30%2.09M34.55%-695.91K79.80%-532.96K77.60%-468.03K
-Change in inventory -249.37%-133.93K-62.73%41.35K-137.74%-47.26K-64.54%272.22K-12.60%-53.61K0.37%89.66K-83.11%110.93K80.70%125.23K187.98%767.69K94.94%-47.61K
-Change in prepaid assets -76.95%53.86K-125.39%-67.33K-110.28%-13.71K255.67%767.81K23.08%135.66K-2.10%233.63K132.42%265.15K649.59%133.37K-1,721.63%-493.22K151.88%110.22K
-Change in payables and accrued expense 81.53%-163.57K132.03%51.32K34.60%-383.42K-245.23%-1.35M-18.46%280.6K-875.52%-885.47K-124.95%-160.26K-244.86%-586.24K882.46%930.5K-78.76%344.12K
-Change in other working capital --0-490.20%-36.75K104.00%11.6K-203.74%-293.12K97.19%-5.45K-102.04%-7.41K114.74%9.42K-264.09%-289.68K222.83%282.56K-787.07%-193.71K
Cash from discontinued investing activities
Operating cash flow -155.24%-3.49M-1,597.28%-3.21M-57.68%-3.76M30.74%-6.22M17.76%-2.68M21.95%-1.37M181.86%214.39K35.62%-2.38M32.95%-8.98M30.85%-3.26M
Investing cash flow
Cash flow from continuing investing activities 86.51%-21.83K72.71%-14.83K0-123.84%-1.1M-281.05%-924.67K-111.02%-161.8K17.08%-54.34K142.99%45K80.79%-489.55K73.23%-242.66K
Net PPE purchase and sale 9.80%-21.83K72.71%-14.83K--093.17%-33.45K100.04%8768.44%-24.2K17.08%-54.34K142.99%45K80.79%-489.55K73.23%-242.66K
Net business purchase and sale ---------------1.06M------------------0----
Cash from discontinued investing activities
Investing cash flow 86.51%-21.83K72.71%-14.83K--0-123.84%-1.1M-281.05%-924.67K-111.02%-161.8K17.08%-54.34K142.99%45K80.79%-489.55K73.23%-242.66K
Financing cash flow
Cash flow from continuing financing activities 10.81M3.02M-35.08K0000023.27%18.13M14.03M
Net common stock issuance --10.81M--2.93M--45.57K--0--0--0--0--04.87%14.43M--10.33M
Proceeds from stock option exercised by employees --------------0--0------------41.55%3.7M--3.7M
Net other financing activities -----------80.64K----------------------------
Cash from discontinued financing activities
Financing cash flow --10.81M--3.02M---35.08K--0--0--0--0--023.27%18.13M--14.03M
Net cash flow
Beginning cash position -70.09%3.9M-68.09%4.11M-48.07%7.9M132.12%15.22M145.76%11.51M100.18%13.04M368.54%12.88M132.12%15.22M-15.82%6.55M-61.54%4.68M
Current changes in cash 576.32%7.29M-230.84%-209.41K-62.21%-3.79M-184.45%-7.31M-134.22%-3.6M16.38%-1.53M-95.75%160.05K38.58%-2.34M803.07%8.66M287.48%10.53M
End cash Position -2.73%11.19M-70.09%3.9M-68.09%4.11M-48.07%7.9M-48.07%7.9M145.76%11.51M100.18%13.04M368.54%12.88M132.12%15.22M132.12%15.22M
Free cash flow -129.69%-3.52M-2,114.90%-3.22M-57.68%-3.76M33.49%-6.3M27.40%-2.54M16.38%-1.53M148.88%160.05K37.40%-2.38M40.60%-9.47M37.68%-3.5M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Mpox (monkeypox)
Mpox (monkeypox)
Intraday-1.40%